07/10/2025
8:00 AM | ADC Therapeutics (Filer)
| Form 424B3 | |
07/09/2025
11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
06/30/2025
4:28 PM | ADC Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/17/2025
4:28 PM | ADC Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SCHEDULE 13G | |
06/13/2025
5:00 PM | ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
8:01 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2025
4:12 PM | ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
4:13 PM | ADC Therapeutics (Issuer)
COUGHLIN TIMOTHY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
6:40 PM | ADC Therapeutics (Subject)
HPWH TH AG (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025
7:14 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
8:14 PM | ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ADCT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ADC Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/24/2025
9:50 AM | ADC Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
04/21/2025
8:20 AM | ADC Therapeutics (Filer)
| Form DEFA14A | |
04/21/2025
8:20 AM | ADC Therapeutics (Filer)
| Form DEF 14A | |
04/09/2025
11:07 AM | ADC Therapeutics (Filer)
| Form PRE 14A | |
03/27/2025
2:28 PM | ADC Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2025
2:34 PM | ADC Therapeutics (Filer)
| Form ARS | |
03/27/2025
6:39 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
5:20 PM | ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:21 PM | ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:22 PM | ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:22 PM | ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:23 PM | ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
5:10 PM | ADC Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G | |
01/13/2025
11:20 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
8:00 PM | ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:37 PM | ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:39 PM | ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:42 PM | ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:35 PM | ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:30 PM | ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
8:00 PM | ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:00 PM | ADC Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/13/2024
3:13 PM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
7:58 AM | ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
| Form SC 13G/A | |
11/13/2024
7:30 AM | ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
| Form SC 13G/A | |
11/07/2024
9:44 AM | ADC Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:54 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:35 PM | ADC Therapeutics (Filer)
| Form DEF 14A | |
09/23/2024
3:39 PM | ADC Therapeutics (Filer)
| Form DEFA14A | |
08/13/2024
11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
A new rule goes live in July — and the banks are quietly cashing in (Ad) A little-known regulation quietly goes into effect this July.
And it's already being exploited by Wall Street and the Big Banks…
It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash.
Not stocks. Not real estate. And definitely not the U.S. dollar.
We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them. To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how |
08/06/2024
3:26 PM | ADC Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/06/2024
9:06 AM | ADC Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2024
6:37 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free ADCT Stock Alerts